Press Release: EnBiotix : EQS-Adhoc: Swiss Takeover Board confirms Absence of an Obligation to make a Public Takeover Offer in connection with planned Enbiotix Merger
EQS Group-Ad-hoc: Polyphor AG / Key word(s): Merger Swiss Takeover Board confirms Absence of an Obligation to make a Public Takeover Offer in connection with
Read full article »
EnBiotix is a Massachusetts-based biotechnology firm that develops and commercializes therapies for the treatment of chronic respiratory disorders.
Read more